Lexeo Therapeutics (LXEO) Other Working Capital Changes: 2022-2023

Historic Other Working Capital Changes for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$318,000.

  • Lexeo Therapeutics' Other Working Capital Changes fell 138.45% to -$318,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 219.52% up from last year.
  • As of Q4 2023, Lexeo Therapeutics' Other Working Capital Changes stood at -$318,000, which was up 34.43% from -$485,000 recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Other Working Capital Changes ranged from a high of $827,000 in Q4 2022 and a low of -$524,000 during Q1 2023.
  • In the last 2 years, Lexeo Therapeutics' Other Working Capital Changes had a median value of -$318,000 in 2023 and averaged -$117,400.
  • Data for Lexeo Therapeutics' Other Working Capital Changes shows a maximum YoY tumbled of 138.45% (in 2023) over the last 5 years.
  • Over the past 2 years, Lexeo Therapeutics' Other Working Capital Changes (Quarterly) stood at $827,000 in 2022, then slumped by 138.45% to -$318,000 in 2023.
  • Its last three reported values are -$318,000 in Q4 2023, -$485,000 for Q3 2023, and -$87,000 during Q2 2023.